• 33076 Citations
  • 78 h-Index
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David R Gandara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Chen, M., Lloyd, K. C., Marcu, L., Chew, H. K., Chaudhari, A. & Yu, A.

National Institutes of Health

7/1/026/30/21

Project: Research project

  • UCDCCC NCTN UG1 PROGRAM

    Gandara, D. R.

    Project: Research project

    UCDCCC NCTN U10 Program

    Gandara, D. R. & Valicenti, R.

    National Institutes of Health

    4/14/142/28/19

    Project: Research project

  • Research Output

    Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials

    imCORE working group of early career investigators, Apr 2020, In : Annals of Oncology. 31, 4, p. 525-531 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

    Coyne, G. O. S., Wang, L., Zlott, J., Juwara, L., Covey, J. M., Beumer, J. H., Cristea, M. C., Newman, E. M., Koehler, S., Nieva, J. J., Garcia, A. A., Gandara, D. R., Miller, B., Khin, S., Miller, S. B., Steinberg, S. M., Rubinstein, L., Parchment, R. E., Kinders, R. J., Piekarz, R. L. & 3 others, Kummar, S., Chen, A. P. & Doroshow, J. H., May 1 2020, In : Cancer Chemotherapy and Pharmacology. 85, 5, p. 979-993 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

    Mack, P. C., Banks, K. C., Espenschied, C. R., Burich, R. A., Zill, O. A., Lee, C. E., Riess, J. W., Mortimer, S. A., Talasaz, A. A., Lanman, R. B. & Gandara, D. R., Jan 1 2020, (Accepted/In press) In : Cancer.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

    Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A. A., Jan 1 2019, In : Investigational New Drugs.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Challenges and approaches to implementing master/basket trials in oncology

    Burd, A., Schilsky, R. L., Byrd, J. C., Levine, R. L., Papadimitrakopoulou, V. A., Herbst, R. S., Redman, M. W., Druker, B. J. & Gandara, D. R., Jul 23 2019, In : Blood Advances. 3, 14, p. 2237-2243 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations